CNBC’s Angelica Peebles and Merck chairman and CEO Rob Davis join 'Squawk Box' to discuss the FDA's approval of the injectable version of Keytruda, pricing for the new injection, navigating the new vaccine landscape, demand for Merck's vaccines, future of drug pricing, and more.

See Full Page